c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia

Tyrosine kinase inhibitor (TKI) therapy for human cancers is not curative, with relapse due to the continuing presence of tumor cells, referred to as minimal residual disease (MRD) cells. MRD stem or progenitor cells survival in the absence of oncogenic kinase signaling, a phenomenon referred to as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Med
Main Authors: Kesarwani, Meenu, Kincaid, Zachary, Gomaa, Ahmed, Huber, Erika, Rohrabaugh, Sara, Siddiqui, Zain, Bouso, Muhammad F., Latif, Tahir, Xu, Ming, Komurov, Kakajan, Mulloy, James C., Cancelas, Jose A., Grimes, H. Leighton, Azam, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424814/
https://ncbi.nlm.nih.gov/pubmed/28319094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4310
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares